[Foods in Focus] Are Oily Fish (Mackerel, Sardines, Saury) Really Good for You? — A Thorough Evidence-Based Review

Bottom Line

• Lower cardiovascular disease risk (eating fish): Level 1 — JELIS trial (18,645 Japanese) and others. 2+ servings/week reduces coronary disease risk
• Lower triglycerides: Level 1 — Meta-analysis: 20–30% reduction, dose-dependent
• EPA supplements (high-risk groups): Level 2 — REDUCE-IT showed 25% MACE reduction with EPA monotherapy; EPA+DHA combined less clear
• Dementia prevention: Level 2–3 — Observational link; RCTs mixed
• Atrial fibrillation risk (supplements): Level 2 — Slight increase; long-term supplementation requires caution

Overall verdict: Eating oily fish is strongly recommended. EPA/DHA supplements are not for everyone — benefits outweigh risks only in specific conditions like high triglycerides or established cardiovascular disease. Healthy people pursuing health gains via supplements have weak evidence support.

🐟 What Are Oily Fish?

Fish with darker, oilier flesh (“blue-backed fish” in Japanese cuisine): mackerel, sardines, Pacific saury, jack mackerel, yellowtail, bonito, tuna. Common feature: high in n-3 (omega-3) polyunsaturated fatty acids (EPA and DHA). Cold-water species tend to have higher concentrations.

Key Players: EPA, DHA, Protein, Vitamin D

• EPA (eicosapentaenoic acid): anti-inflammatory, anti-platelet, triglyceride-lowering
• DHA (docosahexaenoic acid): brain and retinal structural component, neural function
• Protein: ~20 g/100 g, highly bioavailable
• Vitamin D: deficient in many Japanese diets
• Vitamin B12, selenium: present in supportive amounts

EPA/DHA Content of Major Oily Fish (per 100 g)

📊 Evidence #1: Cardiovascular Disease Prevention (Level 1)

JELIS Trial (Historic Japanese RCT)

• 18,645 Japanese with hypercholesterolemia, 5-year follow-up
• Statin alone vs. statin + EPA 1.8 g/day
• Result: 19% reduction in major coronary events (HR=0.81)
• Particularly strong effect in high-triglyceride subgroup
• Influenced global cardiology guidelines — Japan-originated evidence

REDUCE-IT Trial (High-Purity EPA)

• 8,179 high-cardiovascular-risk patients
• Placebo vs. high-purity EPA 4 g/day
• Result: 25% reduction in major adverse cardiovascular events

VITAL Trial (Healthy Adults)

• 25,871 healthy adults aged 50+
• Placebo vs. omega-3 (EPA+DHA) 1 g/day
• Result: no significant difference in overall CV events; myocardial infarction reduced by 28%
• Suggests “supplements for healthy adults” have limited prevention effect

2025 Meta-Analysis (42 studies, 176,253 participants)

• EPA monotherapy: significant reductions in CV mortality, MACE, MI, CHD
• EPA+DHA combined: effect unclear
• Side effects: increased atrial fibrillation, GI symptoms

📊 Evidence #2: Triglyceride Reduction (Level 1)

• EPA/DHA 2–4 g/day: 20–30% reduction in triglycerides
• Clear dose-dependence; mechanism: hepatic VLDL synthesis suppression
• Prescription medications “Epadel” and “Lotriga” are the same EPA in pharmaceutical-grade purity

📊 Evidence #3: Dementia and Brain Function (Level 2–3)

• Observational studies: weekly fish consumption lowers dementia risk (multiple prospective cohorts)
• Rotterdam Study: higher DHA blood levels → lower dementia risk
• RCTs are mixed: limited effect for those already showing cognitive decline
• Current understanding: preventive but not therapeutic

⚠️ “Eating Fish” and “Taking EPA Supplements” Are Not Equivalent

The mackerel-can boom in Japan has caused some confusion: the effect of eating fish and the effect of EPA supplements are not the same.

• Fish contains EPA/DHA plus protein, vitamin D, minerals, taurine
• The benefit of fish consumption includes the broader dietary pattern (replacing red meat, margarine)
• EPA/DHA supplements deliver only the isolated nutrient; long-term use is associated with slightly elevated atrial fibrillation risk
• No such atrial fibrillation signal exists for fish consumption

→ For healthy people, eating fish is the first choice. Supplements are for medical indications such as high triglycerides or elevated cardiovascular risk.

🥗 Practical Guide

Recommended Intake

• 2–3 servings per week, 80–100 g each (Japan MHLW and American Heart Association)
• EPA+DHA total: 250–500 mg/day equivalent
• JELIS used 1.8 g/day, but for healthy people the recommended baseline is sufficient

Cooking Tips (Preserving EPA/DHA)

• Sashimi has minimal loss (essentially zero fat loss)
• Canned (water-packed): pre-cooked, includes the broth — excellent and convenient
• Grilled or simmered: ~20% EPA/DHA loss; deep-fried up to 50% loss
• Foil-baking and steaming: minimize fat loss
• Canned broth contains EPA/DHA — use the liquid, don’t discard

⚠️ Cautions

🆚 Fish vs. EPA/DHA Supplements

📚 Key References

• Yokoyama M et al. JELIS Trial. Lancet. 2007;369:1090-1098.
• Bhatt DL et al. Cardiovascular Risk Reduction with Icosapent Ethyl (REDUCE-IT). N Engl J Med. 2019;380:11-22.
• Manson JE et al. Marine n-3 Fatty Acids and Prevention of CVD/Cancer (VITAL). N Engl J Med. 2019;380:23-32.
• Hu Y et al. Marine Omega-3 Supplementation and CVD: Updated Meta-Analysis. J Am Heart Assoc. 2019;8:e013543.

🔗 Related Articles

• The Mediterranean Diet — The Most Robustly Evidenced Eating Pattern
• Are Avocados Really Good for You? — Evidence Review
• Foods Deep Dive — A Tier A–D View of the Whole Food Landscape

⚠️ Disclaimer

This article is for general health information only. EPA supplements are pharmacologically equivalent to prescription drugs (e.g., Epadel) — those already on medication or with cardiovascular history must consult their physician. Pregnant women: refer to Japan MHLW guidelines on fish consumption.

evidage Editorial Team / Hydrowing Lab Inc. / May 1, 2026

🌟 Featured Long-Form Articles